We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity profile of 99% and Mass Spectrometry (MS) to confirm the precise amino acid profiles of both sequences within the blend
Urva S, Coskun T, Loh MT et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one
This results in coordinated metabolic improvements via tissue-specific activation of signalling pathways that improve glucose homeostasis, decrease inflammation, and help to improve overall cardiovascular and metabolic health